Big Pharma looks to capitalize on success of vitamin D by turning it into a 'drug' for kidney diseas
www.ibtimes.com
With an incredible success rate for vitamin D in treating a myriad of health conditions, it is no wonder that some drug companies are looking for new ways to capitalize on this natural, inexpensive nutrient.